As healthcare has evolved, the ecosystem has become more complex. Today medical affairs is in a position to help facilitate the communication
The findings of real-world evidence studies sometimes contradicts the results of randomized clinical trials. This raises the question of how to reconcile the two.
Where to Publish Drug Trial Results? Traditional Journal Rankings Fail to Deliver their Promised Impact
The JIF has come under growing criticism for its various shortcomings. These include its ineffectiveness as a tool for predicting an article’s impact, the opaque methods used to calculate it, and its potential for misuse.
While such impact scores have their merits for the authors themselves — whose paychecks, reputations, grants, and very careers notoriously depend on the journals they reach and the citations received in their wake — those types of quantitative metrics only tell half the story for Medical Affairs professionals
Getting published in a high-impact journal is no longer the only way to disseminate biomedical knowledge. Conference proceedings, posters, and the emerging practice of nanopublishing are changing the pace and volume of publications.